Viking Therapeutics
VKTX
#3593
Rank
A$4.38 B
Marketcap
$39.07
Share price
-2.61%
Change (1 day)
-60.99%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2024 (TTM): -A$0.17 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.18 Billion28.02%
2023 -A$0.14 Billion24.73%
2022 -A$0.11 Billion25.24%
2021 -A$85.98 Million39.23%
2020 -A$61.76 Million53.21%
2019 -A$40.31 Million16.84%
2018 -A$34.5 Million7.22%
2017 -A$32.18 Million39.68%
2016 -A$23.04 Million-37.05%
2015 -A$36.6 Million6.94%
2014 -A$34.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.79 Billion 358.83%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.88 M-103.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$9.86 Million-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA